GR1003591B - Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο. - Google Patents
Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο.Info
- Publication number
- GR1003591B GR1003591B GR20000100145A GR2000100145A GR1003591B GR 1003591 B GR1003591 B GR 1003591B GR 20000100145 A GR20000100145 A GR 20000100145A GR 2000100145 A GR2000100145 A GR 2000100145A GR 1003591 B GR1003591 B GR 1003591B
- Authority
- GR
- Greece
- Prior art keywords
- anisoyl
- acetylcholic
- enhances
- brain
- release
- Prior art date
Links
- 210000004556 brain Anatomy 0.000 title abstract 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 abstract 5
- DZTVZKSCFQIBMV-UHFFFAOYSA-N 4-[(4-methoxybenzoyl)amino]butanoic acid Chemical compound COC1=CC=C(C(=O)NCCCC(O)=O)C=C1 DZTVZKSCFQIBMV-UHFFFAOYSA-N 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- HKMWGQRYPXHZEN-UHFFFAOYSA-N 2-[(4-methoxybenzoyl)amino]butanoic acid Chemical compound CCC(C(O)=O)NC(=O)C1=CC=C(OC)C=C1 HKMWGQRYPXHZEN-UHFFFAOYSA-N 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000017164 Chronobiology disease Diseases 0.000 abstract 1
- 230000006399 behavior Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται στην χρήση Ν-ανισοϋλ-γ-αμινο-βουτυρικού οξέος (Ν-ανισοϋλ-GABA) ή π-ανισικού οξέος για την παρασκευή μίας φαρμακευτικής σύνθεσης που αυξάνει την απελευθέρωση ακετυλχολίνης (ACh) στον εγκέφαλο. Ειδικότερα, η εφεύρεση αναφέρεται στην χρήση Ν-ανισοϋλ-GABA ή π-ανισικού οξέος για την θεραπευτική αγωγή διαταραχών του κιρκάνιου ρυθμού, διαταραχών του ύπνου, διαταραχών με έλλειψη προσοχής και προβληματικών συμπεριφορών. Η εφεύρεση αναφέρεται επίσης σε φαρμακευτικές συνθέσεις που περιέχουν Ν-ανισοϋλ-GABA ή π-ανισικό οξύ ως αποτελεσματικό συστατικό.ΰ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99108223 | 1999-04-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
GR20000100145A GR20000100145A (el) | 2000-12-29 |
GR1003591B true GR1003591B (el) | 2001-05-22 |
Family
ID=8238054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000100145A GR1003591B (el) | 1999-04-27 | 2000-04-24 | Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο. |
Country Status (24)
Country | Link |
---|---|
US (1) | US20030073744A1 (el) |
JP (1) | JP2000309529A (el) |
KR (1) | KR100372906B1 (el) |
CN (1) | CN1277019A (el) |
AR (1) | AR023763A1 (el) |
AT (1) | AT408836B (el) |
AU (1) | AU3011300A (el) |
BE (1) | BE1013314A3 (el) |
BR (1) | BR0002381A (el) |
CA (1) | CA2307022A1 (el) |
DE (1) | DE10020237A1 (el) |
DK (1) | DK200000687A (el) |
ES (1) | ES2176078A1 (el) |
FI (1) | FI20000977A (el) |
FR (1) | FR2792833B1 (el) |
GB (1) | GB2351662A (el) |
GR (1) | GR1003591B (el) |
IE (1) | IE20000308A1 (el) |
IT (1) | IT1318490B1 (el) |
NL (1) | NL1015043C2 (el) |
PT (1) | PT102456B (el) |
SE (1) | SE0001499L (el) |
TR (1) | TR200001133A2 (el) |
ZA (1) | ZA200002041B (el) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5273731B2 (ja) * | 2009-08-11 | 2013-08-28 | 独立行政法人産業技術総合研究所 | 生体リズムの制御剤 |
CA3119517C (en) * | 2018-11-13 | 2023-08-22 | Xianfeng PENG | Use of acylated derivative of amino acid in preparing animal feed additive |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU21107A3 (es) * | 1978-02-10 | 1988-02-01 | Hoffmann La Roche | Pyrrolidines derivatives |
JPH1081626A (ja) * | 1996-09-06 | 1998-03-31 | Kamiyama:Kk | チロシナーゼ活性阻害剤 |
JPH1081607A (ja) * | 1996-09-06 | 1998-03-31 | Kamiyama:Kk | 抗菌剤 |
-
2000
- 2000-04-21 IT IT2000MI000914A patent/IT1318490B1/it active
- 2000-04-21 FR FR0005180A patent/FR2792833B1/fr not_active Expired - Fee Related
- 2000-04-24 GR GR20000100145A patent/GR1003591B/el unknown
- 2000-04-24 JP JP2000121904A patent/JP2000309529A/ja active Pending
- 2000-04-24 KR KR10-2000-0021630A patent/KR100372906B1/ko not_active IP Right Cessation
- 2000-04-25 AR ARP000101934A patent/AR023763A1/es not_active Application Discontinuation
- 2000-04-25 GB GB0010049A patent/GB2351662A/en not_active Withdrawn
- 2000-04-25 IE IE20000308A patent/IE20000308A1/en not_active IP Right Cessation
- 2000-04-25 DE DE10020237A patent/DE10020237A1/de not_active Withdrawn
- 2000-04-25 AT AT0071600A patent/AT408836B/de not_active IP Right Cessation
- 2000-04-25 DK DK200000687A patent/DK200000687A/da not_active Application Discontinuation
- 2000-04-25 ZA ZA200002041A patent/ZA200002041B/xx unknown
- 2000-04-26 PT PT102456A patent/PT102456B/pt not_active IP Right Cessation
- 2000-04-26 TR TR2000/01133A patent/TR200001133A2/xx unknown
- 2000-04-26 BR BR0002381-7A patent/BR0002381A/pt not_active IP Right Cessation
- 2000-04-26 ES ES200001063A patent/ES2176078A1/es active Pending
- 2000-04-26 FI FI20000977A patent/FI20000977A/fi not_active IP Right Cessation
- 2000-04-26 CA CA002307022A patent/CA2307022A1/en not_active Abandoned
- 2000-04-26 AU AU30113/00A patent/AU3011300A/en not_active Abandoned
- 2000-04-26 BE BE2000/0294A patent/BE1013314A3/fr not_active IP Right Cessation
- 2000-04-26 SE SE0001499A patent/SE0001499L/ unknown
- 2000-04-27 CN CN00118155A patent/CN1277019A/zh active Pending
- 2000-04-27 NL NL1015043A patent/NL1015043C2/nl not_active IP Right Cessation
-
2002
- 2002-12-04 US US10/309,434 patent/US20030073744A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
MXPA04005790A (es) | Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona. | |
YU25399A (sh) | 6-fenilpiridil-2-amino derivati korisni kao nos inhibitori | |
DE60207383D1 (de) | Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen | |
WO2007100366A3 (en) | Quinolone m1 receptor positive allosteric modulators | |
GEP20043303B (en) | Polycycloalkylpurines as Adenosine Receptor Antagonists | |
BR0317888A (pt) | Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos | |
NO20052490L (no) | Dagsdoseringsenheter for melatonin. | |
MX9501848A (es) | Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos. | |
GB0111186D0 (en) | Novel compounds | |
MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
AU2284001A (en) | Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone | |
NZ513096A (en) | Compositions for treating inflammatory response | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
NZ328874A (en) | Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders | |
MX9501849A (es) | Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos. | |
GEP20043267B (en) | Adenosine Receptor Antagonists, Methods of Making and Using the Same | |
GR3036408T3 (en) | Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors | |
UY26426A1 (es) | Nuevos compuestos | |
GR20000100145A (el) | Μεσον για την αυξηση της απελευθερωσης ακετυλχολινης στον εγκεφαλο | |
AU2002224847A1 (en) | N-alkylated gaba compounds, processes for their preparation and their use as medicaments | |
PL360465A1 (en) | Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them | |
TW200510399A (en) | 1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals | |
MXPA04006457A (es) | Alcanosulfonamidas novedosas como antagonistas de endotelina. | |
EA200501591A1 (ru) | Фармацевтическая комбинация для лечения мышечной спастичности и/или боли |